Indian Drugmaker Receives Import Ban After Drug Shortage Ends

The FDA has broadened its import ban against Indian manufacturer Ipca Laboratories to include four drugs previously exempted due to shortage. Only Ipca’s anti-malarial API remains exempted and can be imported into the U.S.
Source: International Pharmaceutical Regulatory Monitor